Cargando…
Use of ketamine for depression and suicidality in cancer and terminal patients: Review of current data
Depression and suicidality are significant challenges faced by cancer patients, particularly those in advanced stages of the disease or nearing the end of life. Conventional antidepressant therapies often have limited effectiveness or delayed onset of action, making the exploration of alternative tr...
Autores principales: | Oyetunji, Aderonke, Huelga, Christian, Bunte, Kailee, Tao, Rachel, Bellman, Val |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIMS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567968/ https://www.ncbi.nlm.nih.gov/pubmed/37842268 http://dx.doi.org/10.3934/publichealth.2023043 |
Ejemplares similares
-
Suicidality Among Men in Russia: A Review of Recent Epidemiological Data
por: Bellman, Val, et al.
Publicado: (2022) -
Rapid Response with Ketamine on Suicidal Cognition in Resistant Depression
por: Thakurta, Rajarshi Guha, et al.
Publicado: (2012) -
Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022) -
Antisuicidal efficacy of ketamine infusion in suicidal patients of depressive disorder
por: Pathak, Umesh, et al.
Publicado: (2021) -
Subcutaneous ketamine in the treatment of depression and suicide risk: case report.
por: Cigognini, M. A., et al.
Publicado: (2023)